CONKLING WILLIAM 4
4 · Protara Therapeutics, Inc. · Filed Jun 4, 2025
Insider Transaction Report
Form 4
CONKLING WILLIAM
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-06-02+200,000→ 200,000 totalExercise: $3.30Exp: 2035-06-01→ Common Stock (200,000 underlying) - Award
Common Stock
2025-06-02+50,000→ 50,000 total
Footnotes (2)
- [F1]The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of June 2, 2025.
- [F2]25% of the shares vest on the one year anniversary of June 2, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.